Literature DB >> 395156

Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.

F W Goldstein, M D Kitzis, J F Acar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 395156     DOI: 10.1093/jac/5.6.705

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children.

Authors:  C H van Niekerk; J van den Ende; H K Hundt; E A Louw
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.

Authors:  P Casey; M Glauser
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

3.  Urinary tract infection.

Authors:  D Greenwood; R Slack
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 4.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination.

Authors:  G Witkowski; H Lode; G Höffken; P Koeppe
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

6.  Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children.

Authors:  G R Fleisher; C M Wilmott; J M Campos
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Authors:  P C Fuchs; A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

9.  Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

10.  Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.

Authors:  M J Gurwith; G E Stein; D Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.